A multi-center randomized controlled clinical trial on treatment of chronic hepatitis C using Vitamin D combine pegylated-interferon alfa-2a+ ribavirin
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Vitamin D analogues (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 29 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
- 21 May 2012 Planned end date (31 Dec 2013) added as reported by Chinese Clinical Trial Register.
- 03 May 2012 New trial record